Raf-induced MMP9 disrupts tissue architecture of human breast cells in three-dimensional culture and is necessary for tumor growth in vivo
- 15 December 2010
- journal article
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 24 (24), 2800-2811
- https://doi.org/10.1101/gad.1990410
Abstract
Organization into polarized three-dimensional structures defines whether epithelial cells are normal or malignant. In a model of morphogenesis, we show that inhibiting key signaling pathways in human breast cancer cells leads to “phenotypic reversion” of the malignant cells. Using architecture as an endpoint, we report that, in all cases, signaling through Raf/MEK/ERK disrupted tissue polarity via matrix metalloproteinase9 (MMP9) activity. Induction of Raf or activation of an engineered, functionally inducible MMP9 in nonmalignant cells led to loss of tissue polarity, and reinitiated proliferation. Conversely, inhibition of Raf or MMP9 with small molecule inhibitors or shRNAs restored the ability of cancer cells to form polarized quiescent structures. Silencing MMP9 expression also reduced tumor growth dramatically in a murine xenograft model. LC-MS/MS analysis comparing conditioned medium from nonmalignant cells with or without active MMP9 revealed laminin 111 (LM1) as an important target of MMP9. LM1 has been implicated in acinar morphogenesis; thus, its degradation by MMP9 provides a mechanism for loss of tissue polarity and reinitiation of growth associated with MMP9 activity. These findings underscore the importance of the dynamic reciprocity between the extracellular matrix integrity, tissue polarity, and Raf/MEK/ERK and MMP9 activities, providing an axis for either tissue homeostasis or malignant progression.This publication has 67 references indexed in Scilit:
- Sustained activation of STAT5 is essential for chromatin remodeling and maintenance of mammary-specific functionThe Journal of cell biology, 2009
- Laminin and biomimetic extracellular elasticity enhance functional differentiation in mammary epitheliaThe EMBO Journal, 2008
- The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transitionOncogene, 2007
- Three-dimensional culture models of normal and malignant breast epithelial cellsNature Methods, 2007
- Study of matrix metalloproteinases and their inhibitors in breast cancerBritish Journal of Cancer, 2007
- Matrix metalloproteinases and the regulation of tissue remodellingNature Reviews Molecular Cell Biology, 2007
- Interdependence of cell attachment and cell cycle signalingCurrent Opinion in Cell Biology, 2006
- Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapyNature Reviews Cancer, 2006
- Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinomaBreast Cancer Research and Treatment, 2004
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002